Human pluripotent stem cells for disease modelling and drug screening. - Wikidata - awgldk - TriplyDB

Human pluripotent stem cells for disease modelling and drug screening.

Human pluripotent stem cells for disease modelling and drug screening.

http://www.wikidata.org/entity/Q37950950

about

Pluripotent Stem Cells: Current Understanding and Future Directions Human pluripotent stem cells on artificial microenvironments: a high content perspective Abnormal oxidative stress responses in fibroblasts from preeclampsia infants.Human pluripotent stem cells: an emerging model in developmental biology.Use of human pluripotent stem cells to study and treat retinopathies Looking for the elusive lung stem cell niche.Comparing ESC and iPSC-Based Models for Human Genetic Disorders Generation of induced pluripotent stem cells from renal tubular cells of a patient with Alport syndrome Patient-derived stem cells: pathways to drug discovery for brain diseases.The pharmacology of regenerative medicine Progress and prospects for genetic modification of nonhuman primate models in biomedical research.Current status of drug screening and disease modelling in human pluripotent stem cells.Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility Stem cells in pediatric cardiology.Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.In vitro neurogenesis: development and functional implications of iPSC technology.Neural Differentiation of Human Pluripotent Stem Cells for Nontherapeutic Applications: Toxicology, Pharmacology, and In Vitro Disease Modeling.Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies.Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology.Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells.Impaired osteogenesis in Menkes disease-derived induced pluripotent stem cells.Stem cells in drug screening for neurodegenerative disease.Progress and prospects in stem cell therapy and drug discovery Significant transcriptional changes in 15q duplication but not Angelman syndrome deletion stem cell-derived neurons.Transgenic mouse analysis of Sry expression during the pre- and peri-implantation stage.Pathological modelling of pigmentation disorders associated with Hutchinson-Gilford Progeria Syndrome (HGPS) revealed an impaired melanogenesis pathway in iPS-derived melanocytes.

P2860

Q26769981-BD652697-0A7E-4221-A681-74EA0506066C Q28656439-9A405F8F-539F-4286-B3E2-BAF9D44EDF4C Q33946049-9F28D325-64D8-40D9-A44B-A3494724DE89 Q34325210-7EE54A39-8C76-4979-97CF-B9A877820999 Q35501343-2733E35C-4959-4DD5-97C5-CFF3F6176B34 Q35529236-2A1703D6-F9F4-4585-BC52-F710CAEEC6B9 Q35750530-02EAB994-9208-4E30-A4EB-FFCB0163D21E Q36000690-E9F8FEFD-D7A8-44CB-AC56-72CE8ACB2A31 Q36718593-45291B7C-A6F6-4C29-BC99-5E8A04377B8C Q36974665-86C92B8E-9893-4006-A24D-DE130FDF68FE Q37271259-4310DF56-4CD2-4FA4-B96E-152BB5CCC837 Q38034129-4731E15A-8EF0-4D8C-83B5-7719E9C7EA92 Q38042792-9B75C8F9-BE52-47B3-B6D1-5CC76CF13FD1 Q38071902-7F21FEE4-305B-41F2-BBC3-2B5601E31C4E Q38107799-2656CCAA-8D03-4050-99A7-3F300E2C7F1C Q38164195-B9E6612F-5C48-4C61-8D6E-0BF38816A600 Q38531969-36A36735-53F2-4001-972F-B403609DC3EC Q38596601-76AFB9A7-0446-4FE3-90FF-2FD0FDEB9625 Q39050993-00B4F58C-74E6-4B8E-9FC5-C0FC819ADD78 Q39265792-12E5A2BB-D708-48DF-870A-F1D13DC6C85A Q39335116-B54D5C37-2DF9-4191-8EE7-AAFD0202FCC3 Q42021732-18258B2E-1EE2-4CCA-B343-E1A847308C0E Q42038314-4B239E33-718D-4119-A879-5DFC71D97FA0 Q42542663-8850DC5E-3926-42FE-9BF0-F1773062CCC1 Q49220418-2802B23A-5F4C-4430-A54B-FADB6B9711B9 Q51343455-A67C01B8-51EB-4FC3-9E3F-1E6EDF1587EF Q55341009-3CED412F-0698-46B2-B64A-088E00CD917A

P2860

Human pluripotent stem cells for disease modelling and drug screening.

http://www.wikidata.org/entity/Q37950950

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Human pluripotent stem cells for disease modelling and drug screening.

@en

Human pluripotent stem cells for disease modelling and drug screening.

@nl

type

label

Human pluripotent stem cells for disease modelling and drug screening.

@en

Human pluripotent stem cells for disease modelling and drug screening.

@nl

prefLabel

Human pluripotent stem cells for disease modelling and drug screening.

@en

Human pluripotent stem cells for disease modelling and drug screening.

@nl

P1433

Q37950950-00C7137F-2389-4E33-9F3F-F303431A16BE

P1476

Q37950950-F195F062-A463-4CFA-B1CA-215A274A49F2

P2093

Q37950950-B9426946-CE4A-4DA8-A700-23FCA23DBB7D

Q37950950-B9460D6F-7521-4F4A-B8CE-33393DAC08A2

Q37950950-CFBE5C48-2B80-4204-8E46-2620A4035B7F

Q37950950-DFB8FF4F-DE02-4520-9F15-44C98E815581

P2860

Q37950950-032D0782-1316-4184-A178-B8769E253A54

Q37950950-0A0C232C-CDDF-4FB6-AA81-4A92FD258981

Q37950950-0FE52B94-03C7-42EF-BCF8-74687361599F

Q37950950-136011C8-84D4-47BB-9A35-54667F3EA558

Q37950950-19C32995-A58E-4545-BD43-F6AC75C9896D

Q37950950-1CFAFCB3-AF80-4B22-B087-FD2295222C63

Q37950950-1D9794DD-BC4D-4C82-9B19-F55C794EE03D

Q37950950-1E42CFDA-79B8-4B9C-A933-452B223E12AA

Q37950950-2097EC61-8F3E-4639-8A3E-5B8A29D65417

Q37950950-20D3A82F-AAB5-4519-97EF-EB5AA938D451

P304

Q37950950-D397B44B-D69A-49FE-8CC9-5F031F474852

P31

Q37950950-F4CE4B84-285C-45E4-8739-061DF09735CA

P356

Q37950950-E8CB3C73-28F0-473C-AC0D-03AD48A13E9A

P407

Q37950950-0C7D7CAC-1A47-49C4-ABF6-054010FD1760

P433

Q37950950-020BEB42-EEDE-4C26-A22D-73CD811B5507

P478

Q37950950-AD8501D9-1C26-4213-A3D3-90B3BF026E5D

P577

Q37950950-ABE555E3-8801-44B5-9EC4-9B6BDF829A6E

P698

Q37950950-B2E0DA55-AEB2-4968-B8AA-6A4656CEE2F0

P921

Q37950950-B231D211-6DCC-4183-BEFC-821BC13A7D0D

P356

P1433

P1476

Human pluripotent stem cells for disease modelling and drug screening.

@en

P2093

Cécile Martinat

http://www.w3.org/2001/XMLSchema#string

Marc Peschanski

http://www.w3.org/2001/XMLSchema#string

Morgane Gauthier

http://www.w3.org/2001/XMLSchema#string

Yves Maury

http://www.w3.org/2001/XMLSchema#string

P2860

Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells

Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons

Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

Modelling schizophrenia using human induced pluripotent stem cells.

Disease-specific induced pluripotent stem cells

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

P304

61-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIES.201100071

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22038777

http://www.w3.org/2001/XMLSchema#string

P921